Regional Representation for Americas

Ottawa, Canadá, 25 - 27 August 2014

The third edition of the Regional Seminar for the OIE National Focal Points for Veterinary Products was celebrated at the city of Ottawa, Canada, and had the purpose of providing participants with knowledge on their rights and responsibilities as OIE National Focal Points in the standard-setting process and also on the implementation and compliance with the OIE international standards.
Click here to read more.


The meeting was held in the city of Ottawa, Canada, and had great support from the Canadian Government. It was held back to back with the Americas Committee on Veterinary Medicines CAMEVET Meeting, which was held from august 27th to the 29th.

Opening speeches were made by the OIE Delegate to Canada, Dr Martine Dubuc, Dr. Harpreet Kochhar, Chief Veterinary Officer of the Canadian Food Inspection Agency, the OIE Regional Representative for the Americas Dr. Luis Barcos, the OIE Sub-Regional Representative for Central America, Dr Montserrat Arroyo Kuribreña, and the Deputy Head of the Scientific and Technical Department of the OIE, Dr Elisabeth Erlacher- Vindel.

The workshop included two and a half days of lectures, and three group sessions in which participants worked in three teams to go through three different questionnaires regarding diagnostic kit registration, anti-parasitics and a third one on data collection on antimicrobial usage.

A brief update on the activities of the OIE in the field of veterinary products, including the OIE standards as well as the procedure for the adoption and amendment of its Chapters was provided for newly appointed Focal Points in an introductory session on the first day.



A review on the results of the previous Veterinary Product Focal Point training was presented by Dr. Freischem allowing later on for presentations by three different countries, which helped getting feedback on expectations for the workshop as well as for future Focal Point activities.

The workshop was divided in different sessions. The first one was on the OIE Standards on General Principles and methods of validation of diagnostic assays for infectious diseases and on the OIE Procedure for the registration of diagnostic kits. Working Groups were set up to discuss the current status of each country regarding the registration of diagnostic kits.

Another session was aimed at presenting an update on the issue of responsible antimicrobial use and resistance, and focused on the recommendations of the OIE, as well as options on how to set up a national antimicrobial resistance and usage monitoring system. A follow up working session allowed testing and validating the proposed template that OIE will implement in the near future to collect antimicrobial usage data in animals.

Another topic covered in the workshop was the use of anti-parasitic drugs; this issue was important for the region, although it was evident that the procedures for the approval, control of quality and usage of these products differ in the different countries. It was concluded that work needs to be done to provide Member Countries better guidance regarding anti-parasitic drugs.

The last session highlighted regional issues and focused on harmonisation of assessment of marketing authorisation applications between Canada and the US, highlighted the role of the private veterinarian in controlling antimicrobial resistance (AMR), addressed options to control counterfeit veterinary medicinal products, and informed on use of veterinary medicines in aquaculture.

Participants took part in discussions on the adoption and revision of the OIE standards, and their role as Focal Points, as well as all the practical activities they performed.